Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-21

Clinical Trial Update: 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]

View source ↗

Summary

Clinical trial comparing Alocross with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alocross
  • Vismed

Snippet

Sponsor: Santen SAS | Conditions: Dry Eye Syndromes | NA | Status: ACTIVE_NOT_RECRUITING